Boston Scientific Corp Files 8-K
Ticker: BSX · Form: 8-K · Filed: May 28, 2025 · CIK: 885725
| Field | Detail |
|---|---|
| Company | Boston Scientific CORP (BSX) |
| Form Type | 8-K |
| Filed Date | May 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-structure, debt-filing, sec-filing
Related Tickers: BSX
TL;DR
BSX filed an 8-K on 5/28/25, mostly corporate structure and debt notes due 2027.
AI Summary
On May 28, 2025, Boston Scientific Corporation (BSX) filed an 8-K report. The filing primarily contains information related to their corporate structure and financial instruments, including common stock and senior notes due in 2027. No specific new business events or material financial changes were detailed in this particular filing.
Why It Matters
This filing provides an update on Boston Scientific's corporate and financial structure, which is important for investors to track the company's ongoing financial health and obligations.
Risk Assessment
Risk Level: low — The filing is routine and does not disclose any new material adverse events or significant financial changes.
Key Numbers
- 0000885725 — Accession Number (Unique identifier for the SEC filing)
- 04-2695240 — IRS Employer Identification No. (Tax identification for the company)
Key Players & Entities
- Boston Scientific Corporation (company) — Registrant
- BSX (company) — Ticker Symbol
- May 28, 2025 (date) — Filing Date
- 2027 (date) — Maturity Year for Senior Notes
FAQ
What is the primary purpose of this 8-K filing for Boston Scientific Corporation?
The primary purpose of this 8-K filing is to report information related to the company's corporate structure and financial instruments, including common stock and senior notes due in 2027.
When was this 8-K report filed by Boston Scientific Corporation?
This 8-K report was filed on May 28, 2025.
What specific financial instruments are mentioned in the filing?
The filing mentions common stock and senior notes due in 2027.
What is Boston Scientific Corporation's principal executive office address?
Boston Scientific Corporation's principal executive office is located at 300 Boston Scientific Way, Marlborough, Massachusetts 01752-1234.
Does this filing indicate any new business operations or material events for Boston Scientific?
Based on the provided text, this filing appears to be routine and primarily concerns corporate and financial structure information, rather than detailing new business operations or material events.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 28, 2025 regarding BOSTON SCIENTIFIC CORP (BSX).